Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T09:58:48.373Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacological treatment of extreme self-injurious behavior in autism

Published online by Cambridge University Press:  16 April 2020

R Knabe  and
P Bovier
R Knabe
Affiliation:
Division de Psychiatrie du Développement Mental, Chemin du petit Bel-Air 2, CH-1225, Chêne-Bourg, Switzerland
P Bovier
Affiliation:
Division de Psychiatrie du Développement Mental, Chemin du petit Bel-Air 2, CH-1225, Chêne-Bourg, Switzerland
Get access

Summary

Two autistic patients suffering from extreme cases of self-injurious behavior received an association of a sedative neuroleptic, a β-adrenoceptor blocking agent and an opiate antagonist. Within a few weeks after introduction, self-injurious behavior ended. Both patients have been followed-up for more than two years and have not relapsed.

Keywords

infantile autismself-injurious behaviorβ-adrenoceptor blockeropiate antagonistneuroleptics
Type
Short communication
Information
European Psychiatry , Volume 7 , Issue 6 , 1992 , pp. 297 - 298
Copyright
Copyright © Elsevier, Paris 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, LTCampbell, MGrega, DMPerry, RSmall, AMGreen, WH (1984) Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 141, 10, 1195–1202Google ScholarPubMed
Anderson, LTCampbell, MAdams, PSmall, AMPerry, RShell, J (1989) The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 19, 2, 227–239CrossRefGoogle ScholarPubMed
Leboyer, MBouvard, MPLaunay, JMTabuteau, FWaller, DDugas, MKerdelhue, BLensing, PPanksepp, J (1992) Brief report: A double-blind study of naltrexone in infantile autism. J Autism Dev Disord 22, 2, 309–319CrossRefGoogle ScholarPubMed
Ratey, JJLindem, KJ (1991)β-blockers as primary treatment for aggression and self-injury in the developmentally disabled.In: Mental Retardation: Developing Pharmacotherapies (Ratey, JJ ed). Progress in Psychiatry. American Psychiatric Press, Washington and London, 51–81Google Scholar
Submit a response

Comments

No Comments have been published for this article.